GDF15 and tuberculosis: This study aimed to determine whether baseline GDF-15 levels can predict myelosuppression in RR-TB patients treated with linezolid.<h4>Methods</h4>The study included patients with RR-TB from three referral hospitals who were treated with a linezolid-containing regimen for at least 4 weeks.